Gavin T. Malenfant - Jul 7, 2022 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Operating Officer
Signature
/s/ Jason L. Langford, Attorney-in-Fact for Gavin T. Malenfant
Stock symbol
PMN
Transactions as of
Jul 7, 2022
Transactions value $
$0
Form type
3
Date filed
7/7/2022, 07:26 PM
Next filing
Aug 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMN Option (right to buy) Jul 7, 2022 Common Shares 58.3K $11.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 The option agreement provides that the option vested 1/4 immediately with the balance vesting ratably over 36 months. The option was granted on September 22, 2021.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney